Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic
  • Search Hotels in Menlo Park

  • ROOMS:

Biotechnology & Pharmaceutical Services Outsourcing Market Size To Reach $91.4 Billion Till 2028 – Regional Scope, Competitive Landscape and End-use Perception Analysis By Million Insights

Biotechnology & Pharmaceutical Services Outsourcing Market Size To Reach $91.4 Billion Till 2028 - Regional Scope, Competitive Landscape and End-use Perception Analysis By Million InsightsMillion Insights - World's Fastest Growing Market Research DatabaseAccording to new report available with Million Insights, the global biotech & pharma services outsourcing industry research report offers thorough insights on services, trends, size and revenue. It also offers ready, data-driven answers to several industry-level questions.

The global biotechnology & pharmaceutical services outsourcing market size is estimated to arrive at USD 91.4 billion by 2028. It is projected to develop by 5.2% CAGR during the forecast period.

The greater demand for biologics together with miniature molecules has initiated the growth of service range of Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs), in favor of pharmaceutical as well as biotechnology manufacture.

Small sized biotech and Pharma companies are in front of the challenges like costly capability and short of important proficiency, whilst carrying out various functions like internal improvement, training & education, product design & development, regulatory affairs, product testing & validation and product maintenance.

To download the sample PDF of Biotechnology & Pharmaceutical Services Outsourcing Market Report “please” click here: 


Sequentially, this has produced profitable occasions for the enlargement of CROs and CMOs. Contract services are increasing and turning into planned, strategic, and targeted. These factors are likely to perform a crucial part in increasing the share of CROs and CMOs in the general market for biotechnology & pharmaceutical services outsourcing. 

Ending of copyright, increasing pricing pressure and authoritarian challenges have caused reduction of margins in the pharmaceutical and biotech manufacturing. Contract services present savings in the prices to their customers in addition to, furthermore, assist in saving time consumed in the procedure and administration of a manufacture as well as research amenities. 

Moreover, the outsourcing services help in conquer trade obstacles in doing business and make possible the entrance of the companies into overseas markets. Due to these compensations, a number of firms decide to contract out services instead of spending funds on manufacturing machineries and employing experienced manual labor. 

To browse report summary & detailed TOC, “please” click the link below: 


Further key findings from the report suggest:

• In terms of revenue share plus the CAGR, the Pharma end-use sector is likely to direct the biotechnology & pharmaceutical services outsourcing market, during the forecast period, because of the growing competition and pressure of pricing, the pharma companies contract out their in-house actions, on a bigger level

• In 2020, the consulting service sector dominated the market and is expected to maintain its leading place, during the forecast period

• Due to the existence of pharmaceutical and biotechnology companies, in addition to the high-pitched quality of the services presented by the CMOs and CROs within the region, North America was the leading local market for the biotechnology & pharmaceutical services outsourcing, in 2020

• On the other hand, Asia Pacific is expected to record the highest CAGR, during the forecast period, due to the enhanced authoritarian frameworks, the greater scope for savings of expenditure, accessibility of low-priced manual labor as well as skillful human resources, and speedy enlargement of the pharmaceutical and biotechnology business, within the region

• Pharmaceutical and biotechnology companies are, gradually more, choosing for the consulting services owing to the factors, like the rising figure of counterfeit cases and inconsistency in intellectual property rights

Million Insights segmented the global biotechnology & pharmaceutical services outsourcing market based on End Use, Service, and Region.

Biotech & Pharma Services Outsourcing Service Outlook (Revenue, USD Million, 2016 - 2028)

    • Consulting

        • Regulatory Compliance

        • Remediation

        • Quality Management Systems Consulting

        • Others

    • Auditing & Assessment

        • Regulatory Affairs

        • Clinical Trial Applications & Product Registration

        • Regulatory Writing & Publishing

        • Legal Representation

        • Others

    • Product Maintenance

    • Product Design & Development

    • Product Testing & Validation

    • Training & Education

    • Others

Biotech & Pharma Services Outsourcing End-use Outlook (Revenue, USD Million, 2016 - 2028)

    • Pharma Companies

    • Biotech Companies

Biotech & Pharma Services Outsourcing Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

        • U.S.

        • Canada

    • Europe

        • U.K.

        • Germany

        • France

        • Italy

        • Spain

    • Asia Pacific

        • Japan

        • China

        • India

        • Australia

        • South Korea

    • Latin America

        • Brazil

        • Mexico

        • Argentina

    • Middle East & Africa

        • South Africa

        • Saudi Arabia

        • UAE


Various companies for biotechnology & pharmaceutical services outsourcing market are:

    • ICON plc

    • Charles River Laboratories

    • Concept Heidelberg GmbH

    • Lachman Consultant Services, Inc.

    • IQVIA

    • PRA Health Sciences

    • Covance Inc.

    • GMP Pharmaceuticals Pty Ltd.

    • Parexel International Corporation

    • The Quantic Group

Browse latest market research reports available with Million Insights:

• Pre-engineered Building Market: The global pre-engineered building (PEB) market size was accounted for USD 9.73 billion, in 2017 and anticipated to grow with a CAGR of 15.5%, during the forecast period, 2018 to 2025.

• Virtual Production Market: With reference to the report published, the global virtual production market size was prized by USD 1260.5 million in 2019. It is estimated to witness a 15.8% CAGR from 2020 to 2027.

About Million Insights

Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive marketplace that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.

Media Contact
Company Name: Million Insights
Contact Person: Ryan Manuel
Email: Send Email
Phone: 91-20-65300184
Address:Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar
City: Pune
State: Maharashtra
Country: India

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.